Clinical Trial Update: A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 trial update describes a single- and multiple-ascending dose study of LT-002-158 tablets in healthy adult volunteers, with recruitment ongoing and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Hidradenitis Suppurativa

Drugs mentioned

• LT-002-158 tablets (LT-002-158)

Snippet

Sponsor: Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | Conditions: Healthy Volunteer, Hidradenitis Suppurativa | Phase 1 | Status: RECRUITING